HB Wealth Management LLC Purchases New Shares in Molina Healthcare, Inc $MOH

Posted by George Bondi on Jul 12th, 2026

HB Wealth Management LLC purchased a new position in Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 3,976 shares of the company’s stock, valued at approximately $530,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. AQR Capital Management LLC increased its stake in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after purchasing an additional 201,772 shares during the last quarter. Invesco Ltd. boosted its position in shares of Molina Healthcare by 24.2% in the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after purchasing an additional 329,679 shares in the last quarter. Victory Capital Management Inc. increased its position in Molina Healthcare by 46.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock valued at $244,796,000 after buying an additional 447,078 shares in the last quarter. Finally, 8 Knots Management LLC bought a new stake in Molina Healthcare in the fourth quarter worth $198,942,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on MOH shares. Barclays reduced their price objective on shares of Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating for the company in a research note on Wednesday. Cantor Fitzgerald boosted their target price on Molina Healthcare from $144.00 to $209.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Royal Bank Of Canada boosted their price objective on shares of Molina Healthcare from $216.00 to $248.00 and gave the company a “sector perform” rating in a report on Thursday. JPMorgan Chase & Co. increased their price target on Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a report on Monday, June 8th. Finally, Wall Street Zen raised Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $185.88.

Check Out Our Latest Stock Analysis on MOH

Molina Healthcare Price Performance

Shares of NYSE MOH traded down $0.15 during mid-day trading on Friday, reaching $231.94. The company’s stock had a trading volume of 688,136 shares, compared to its average volume of 968,227. The stock has a fifty day moving average of $199.29 and a two-hundred day moving average of $173.08. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $243.50. The firm has a market capitalization of $12.08 billion, a PE ratio of 68.62 and a beta of 0.74.

Molina Healthcare (NYSE:MOH – Get Free Report) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same quarter in the prior year, the business earned $6.08 earnings per share. Molina Healthcare’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by company insiders.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.